Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas
Primary Purpose
Anal Fistula
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ethibond suture
Vessel loop
Sponsored by
About this trial
This is an interventional treatment trial for Anal Fistula
Eligibility Criteria
Inclusion Criteria: Adult patients aged 18 years or older of either sex who present with CAF will be included. Both cryptoglandular fistulas and fistulas secondary to inflammatory bowel disease (IBD) Exclusion Criteria: Simple anal fistulas Fistulas secondary to malignancy or irradiation therapy Pregnant women Patients with pre-existing setons
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Ethibond suture
Vessel loop
Arm Description
Patients with complex anal fistula will undergo placement of Ethibond™ 1 suture as a drainage seton
Patients with complex anal fistula will undergo placement of vessel loop as a drainage seton
Outcomes
Primary Outcome Measures
Drainage of perianal sepsis
Change in the perianal disease activity index
Durability
Incidence and timing of seton break/fall
Secondary Outcome Measures
Quality of life score
Change in the anal fistula quality of life score
Healing
Complete healing of the anal fistula evidenced by absence of external opening and discharge
Continence state
Change in the Wexner incontinence score
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05933343
Brief Title
Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas
Official Title
Ethibond Suture Compared to Vessel Loop as Draining Seton for Complex Anal Fistulas; a Multicenter Randomized Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 10, 2023 (Anticipated)
Primary Completion Date
January 30, 2025 (Anticipated)
Study Completion Date
July 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Cleveland Clinic
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Drainage seton is usually placed for long-term control of symptoms, and hence it has to be effective in drainage of infection, durable, and comfortable to the patients. The present study assumes that different seton materials would attain different drainage capacities, variable durability and impact on QoL. Therefore, the study aims to compare two commonly used seton materials; Ethibond suture and vessel loop, in the management of CAF in terms of effectiveness in draining infection, percent of seton break and its timing, and change in patients' QoL as measured by a validated questionnaire.
Detailed Description
The use of seton as a surgical therapy for fistulous disease has been first described by Hippocrates in 430 BCE. Since then several authors have used either cutting or drainage seton to treat CAF. Different materials have been used as seton, including sutures, stainless steel wires, catheters, cables, silicone, and rubber bands. While the main aim of a drainage seton is to simply drain sepsis and control symptoms in the long term, cutting setons are mainly used for eradiation of the fistula pathology by cutting through the fistula tract and anal sphincter muscles, yet at the cost of an increased risk of fecal incontinence (FI).
As the purpose of a drainage seton is to provide long-term, durable drainage of perineal sepsis and control of symptoms, namely discharge, the seton material can have an impact on its function and durability. A review of the variations in seton types and materials showed that the success rates of suture seton (silk, prolene or nylon suture) are higher than those of Penrose drains and catheters. However, there is a paucity of data on the impact of the seton material on the durability of seton and quality of life (QoL)
Drainage seton is usually placed for long-term control of symptoms, and hence it has to be effective in drainage of infection, durable, and comfortable to the patients. The present study assumes that different seton materials would attain different drainage capacities, variable durability, and impact on QoL. Therefore, the study aims to compare two commonly used seton materials; Ethibond suture and vessel loop, in the management of CAF in terms of effectiveness in draining infection, percent of seton break and its timing, and change in patients' QoL as measured by a validated questionnaire.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anal Fistula
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
140 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Ethibond suture
Arm Type
Active Comparator
Arm Description
Patients with complex anal fistula will undergo placement of Ethibond™ 1 suture as a drainage seton
Arm Title
Vessel loop
Arm Type
Active Comparator
Arm Description
Patients with complex anal fistula will undergo placement of vessel loop as a drainage seton
Intervention Type
Procedure
Intervention Name(s)
Ethibond suture
Intervention Description
An Ethibond™ 1 suture will be placed as a drainage seton for complex anal fistula
Intervention Type
Procedure
Intervention Name(s)
Vessel loop
Intervention Description
A vessel loop will be placed as a drainage seton for complex anal fistula
Primary Outcome Measure Information:
Title
Drainage of perianal sepsis
Description
Change in the perianal disease activity index
Time Frame
3 and 12 months
Title
Durability
Description
Incidence and timing of seton break/fall
Time Frame
within 12 months
Secondary Outcome Measure Information:
Title
Quality of life score
Description
Change in the anal fistula quality of life score
Time Frame
3 and 12 months
Title
Healing
Description
Complete healing of the anal fistula evidenced by absence of external opening and discharge
Time Frame
12 months
Title
Continence state
Description
Change in the Wexner incontinence score
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patients aged 18 years or older of either sex who present with CAF will be included. Both cryptoglandular fistulas and fistulas secondary to inflammatory bowel disease (IBD)
Exclusion Criteria:
Simple anal fistulas
Fistulas secondary to malignancy or irradiation therapy
Pregnant women
Patients with pre-existing setons
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sameh H Rizkalla, M.D.
Phone
5513309230
Email
rizkals@ccf.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven D Wexner, M.D.
Organizational Affiliation
Cleveland Clinic Florida
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas
We'll reach out to this number within 24 hrs